Search

Search Constraints

You searched for: Author/Creator Ding, N

Search Results

9. OP01 Withdrawal of infliximab or anti-metabolite therapy in Crohn's Disease patients in sustained remission on combination therapy: A randomized unblinded controlled trial (SPARE). (21st January 2022)

10. P494 A serum metabolite panel predicts Crohn's disease relapse in patients discontinuing infliximab and continuing antimetabolite therapy: sub-analysis of the SPARE Trial. (21st January 2022)